NCT02769702View on ClinicalTrials.gov

Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis

PHASE4TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

January 6, 2017

Study Completion Date

January 6, 2017

Conditions

Uveitis

Interventions

DRUG

Acthar

Acthar 80 IU SC twice a week

Trial Locations (1)

63110

Washington University in St. Louis, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Mallinckrodt

INDUSTRY

lead

Washington University School of Medicine

OTHER